USPTO serial 86156788
EIRGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 29, 2016
- Examiner
- KUYKENDALL, LYNDSEY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with EIRGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sean P. McMahon
Sean P. McMahon Sean P. McMahon, PLLC209 Garth Road 1IScarsdale, NY 10583UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals used in industry, science and photography; chemical substances for preserving foodstuffs; adhesives used in industry; chemical products and reagents for use in biotechnology other than for medical or veterinary use; biological preparations for use in biotechnology other than for medical use | SECTION 8 - CANCELLED | — |
| 003 | cosmetic sun-tanning preparations; tanning creams | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations and substances for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; sanitary preparations for medical use; prescription pharmaceutical and biotechnological preparations for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; biological preparations for medical purposes, namely, for use in biotechnology; chemical preparations and reagents for use in biotechnology for medical and veterinary use; injectable solutions for medical purposes, namely, injectable pharmaceuticals for cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders; dietetic foods, namely, pasta, crackers, and bread, food supplements, infusions, drinks and beverages all adapted for medical use; all purpose disinfectants, oral disinfectants for medical and hygienic purposes, disinfectants for hygienic and sanitary purposes, disinfectants for medical instruments; syrups for pharmaceutical purposes, namely, cough syrups; vaccines; syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use; pre-filled disposable syringes and hypodermic syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use | SECTION 8 - CANCELLED | — |
| 010 | Surgical apparatus and instruments for use in general surgery and surgical procedures; medical apparatus and instruments for use in general surgery; dental surgical apparatus and instruments for use in a dental surgery; veterinary surgical apparatus and instruments for use in a veterinary surgery; orthopedic braces, footwear, belts, corsets, trousers, inserts for footwear and soles; orthopedic joint implants, supports and bandages; sutures; syringes for injections; disposable syringes; inhalers for medical use; injection instruments with needles for medical use; injection instruments without needles for medical use; medical and dental syringes | SECTION 8 - CANCELLED | — |
| 042 | The provision of information on the subject of research and development, drug development and product evaluation all in the field of pharmaceuticals and biotechnology; scientific and industrial research relating to pharmaceuticals and biotechnology | SECTION 8 - CANCELLED | — |
| 044 | Medical services; facial beauty treatment services; consultancy services relating to beauty; beauty salons; providing information on hygiene and beauty; providing health information services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EirGen Pharma Limited
- Other trademarks owned by EirGen Pharma Limited
- Other trademarks owned by EirGen Pharma Limited
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EIRGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 22, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 22, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 22, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 22, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 22, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 18, 2017 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Apr 18, 2017 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Mar 29, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 24, 2016 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Feb 24, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 16, 2016 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Feb 16, 2016 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Aug 25, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 30, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 30, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 26, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 19, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 19, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 19, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 28, 2015 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 10, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 8, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 8, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 8, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 8, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 8, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 19, 2014 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 19, 2014 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 19, 2014 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 5, 2014 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 7, 2014 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 23, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 22, 2014 | ALIE | ASSIGNED TO LIE | — |
| Sep 8, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 8, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 6, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 5, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 9, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 16, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 7, 2014 | NWAP | NEW APPLICATION ENTERED | — |